162 related articles for article (PubMed ID: 29427676)
1. In vitro susceptibility to ST-246 and Cidofovir corroborates the phylogenetic separation of Brazilian Vaccinia virus into two clades.
Pires MA; Rodrigues NFS; de Oliveira DB; de Assis FL; Costa GB; Kroon EG; Mota BEF
Antiviral Res; 2018 Apr; 152():36-44. PubMed ID: 29427676
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype.
Kornbluth RS; Smee DF; Sidwell RW; Snarsky V; Evans DH; Hostetler KY
Antimicrob Agents Chemother; 2006 Dec; 50(12):4038-43. PubMed ID: 16982794
[TBL] [Abstract][Full Text] [Related]
3. ST-246 is a key antiviral to inhibit the viral F13L phospholipase, one of the essential proteins for orthopoxvirus wrapping.
Duraffour S; Lorenzo MM; Zöller G; Topalis D; Grosenbach D; Hruby DE; Andrei G; Blasco R; Meyer H; Snoeck R
J Antimicrob Chemother; 2015 May; 70(5):1367-80. PubMed ID: 25630650
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new Vaccinia virus isolate reveals the C23L gene as a putative genetic marker for autochthonous Group 1 Brazilian Vaccinia virus.
Assis FL; Almeida GM; Oliveira DB; Franco-Luiz AP; Campos RK; Guedes MI; Fonseca FG; Trindade GS; Drumond BP; Kroon EG; Abrahão JS
PLoS One; 2012; 7(11):e50413. PubMed ID: 23189200
[TBL] [Abstract][Full Text] [Related]
5. Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.
Duraffour S; Vigne S; Vermeire K; Garcel A; Vanstreels E; Daelemans D; Yang G; Jordan R; Hruby DE; Crance JM; Garin D; Andrei G; Snoeck R
Antivir Ther; 2008; 13(8):977-90. PubMed ID: 19195323
[TBL] [Abstract][Full Text] [Related]
6. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
[TBL] [Abstract][Full Text] [Related]
7. Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.
Jesus DM; Costa LT; Gonçalves DL; Achete CA; Attias M; Moussatché N; Damaso CR
J Virol; 2009 Nov; 83(22):11477-90. PubMed ID: 19726515
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
Quenelle DC; Collins DJ; Kern ER
Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818
[TBL] [Abstract][Full Text] [Related]
9. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
Quenelle DC; Collins DJ; Wan WB; Beadle JR; Hostetler KY; Kern ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
[TBL] [Abstract][Full Text] [Related]
10. Real-time PCR assay to identify variants of Vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil.
de Souza Trindade G; Li Y; Olson VA; Emerson G; Regnery RL; da Fonseca FG; Kroon EG; Damon I
J Virol Methods; 2008 Sep; 152(1-2):63-71. PubMed ID: 18602170
[TBL] [Abstract][Full Text] [Related]
11. Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®.
Santos-Fernandes É; Beltrame CO; Byrd CM; Cardwell KB; Schnellrath LC; Medaglia ML; Hruby DE; Jordan R; Damaso CR
Antiviral Res; 2013 Mar; 97(3):301-11. PubMed ID: 23257396
[TBL] [Abstract][Full Text] [Related]
12. Zoonotic Brazilian Vaccinia virus: from field to therapy.
Kroon EG; Mota BE; Abrahão JS; da Fonseca FG; de Souza Trindade G
Antiviral Res; 2011 Nov; 92(2):150-63. PubMed ID: 21896287
[TBL] [Abstract][Full Text] [Related]
13. Polycyclic N-benzamido imides with potent activity against vaccinia virus.
Torres E; Duque MD; Camps P; Naesens L; Calvet T; Font-Bardia M; Vázquez S
ChemMedChem; 2010 Dec; 5(12):2072-8. PubMed ID: 20967819
[TBL] [Abstract][Full Text] [Related]
14. Assessing the variability of Brazilian Vaccinia virus isolates from a horse exanthematic lesion: coinfection with distinct viruses.
Campos RK; Brum MC; Nogueira CE; Drumond BP; Alves PA; Siqueira-Lima L; Assis FL; Trindade GS; Bonjardim CA; Ferreira PC; Weiblen R; Flores EF; Kroon EG; Abrahão JS
Arch Virol; 2011 Feb; 156(2):275-83. PubMed ID: 21080203
[TBL] [Abstract][Full Text] [Related]
15. Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans.
Trindade GS; Emerson GL; Sammons S; Frace M; Govil D; Fernandes Mota BE; Abrahão JS; de Assis FL; Olsen-Rasmussen M; Goldsmith CS; Li Y; Carroll D; Guimarães da Fonseca F; Kroon E; Damon IK
Viruses; 2016 Dec; 8(12):. PubMed ID: 27973399
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of vaccinia virus replication by two small interfering RNAs targeting B1R and G7L genes and their synergistic combination with cidofovir.
Vigne S; Duraffour S; Andrei G; Snoeck R; Garin D; Crance JM
Antimicrob Agents Chemother; 2009 Jun; 53(6):2579-88. PubMed ID: 19307376
[TBL] [Abstract][Full Text] [Related]
17. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.
Yang G; Pevear DC; Davies MH; Collett MS; Bailey T; Rippen S; Barone L; Burns C; Rhodes G; Tohan S; Huggins JW; Baker RO; Buller RL; Touchette E; Waller K; Schriewer J; Neyts J; DeClercq E; Jones K; Hruby D; Jordan R
J Virol; 2005 Oct; 79(20):13139-49. PubMed ID: 16189015
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of cidofovir resistant vaccinia viruses.
Becker MN; Obraztsova M; Kern ER; Quenelle DC; Keith KA; Prichard MN; Luo M; Moyer RW
Virol J; 2008 May; 5():58. PubMed ID: 18479513
[TBL] [Abstract][Full Text] [Related]
19. Brazilian vaccinia viruses and their origins.
Trindade GS; Emerson GL; Carroll DS; Kroon EG; Damon IK
Emerg Infect Dis; 2007 Jul; 13(7):965-72. PubMed ID: 18214166
[TBL] [Abstract][Full Text] [Related]
20. Activity of the anti-orthopoxvirus compound ST-246 against vaccinia, cowpox and camelpox viruses in cell monolayers and organotypic raft cultures.
Duraffour S; Snoeck R; de Vos R; van Den Oord JJ; Crance JM; Garin D; Hruby DE; Jordan R; De Clercq E; Andrei G
Antivir Ther; 2007; 12(8):1205-16. PubMed ID: 18240860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
